top of page

Comprehensive Genomic Profiling from FFPE Tissue

Doctor Consulting Patient

Integrated Tumor Profiling for Precision Oncology

Key Benefits

for Clinicians

INTEGRATED REPORTING

Variant and biomarker data delivered together in one unified workflow.

ADVANCES RESEARCH

Enables deeper research into targeted therapy and immuno-oncology.

STREAMLINED ORDERING

Simplified sample requirements — a single FFPE block is all that's needed.

SUPPORTS CLINICAL TRIALS

Helps assess patient eligibility for targeted and immunotherapy trials.

Doctor In Consultation

Clinical Research Use Cases

  • Molecular stratification for basket trials

  • Retrospective biomarker correlation studies

  • Immuno-oncology patient subset discovery

  • Tumor heterogeneity and resistance mechanism profiling

Ordering & Logistics

  • Sample type: FFPE tissue (≥20% tumor content preferred)

  • Turnaround time: ~14 days from sample receipt

  • Performed in a CLIA-certified & CAP-accredited lab

  • Modular reporting available upon request

Are You Seeing the

Full Picture?

Let’s Redefine Cancer Care Together

Partner with Circulogene to bring integrated, single-block genomic profiling to your patients.
Get results in approximately 14 days!

Performance Characteristics

Test
Panels
Source
Collection
Input Requirement
Analytical Sensitivity (LOD95)
Specificity
OncoGenDx - DNA
SNVs, Indels, CNV, MSI, TMB (486 genes)
Tissue
FFPE
>20% tumor
> 98% at 5% VAF
>99.9%
OncoGenDx - RNA
RNA Fusion events (72 genes)
Tissue
FFPE
>20% tumor
> 99% at 5%VAF
>99.9%
bottom of page